CHR Citadelle Report issue

Academic/Hospital Phase 2 Phase 3 Phase 4

Organization Overview

First Clinical Trial
2004
NCT00557817
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2022

Timeline

NOW
  • Now

Alternative names

Centre Hospitalier Regional de la Citadelle | Centre Hospitalier Régional de la Citadelle | CHR Citadelle-CHU liège